Clinical Medicine: Pharmacologic inhibition of JAK-STAT signaling promotes hair growth

Science Advances

Volumn 1, Issue 9, 2015, Pages

  Harel, Sivan ^a   Higgins, Claire A ^a   Cerise, Jane E ^a   Dai, Zhenpeng ^a   Chen, James C ^a   Clynes, Raphael ^a   Christiano, Angela M ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ACTIVATION; STEM CELLS;

CLINICAL MEDICINE; DERMAL PAPILLA; GROWTH PHASE; HAIR FOLLICLES; MOLECULAR SIGNATURES; SIGNAL TRANSDUCERS; SMALL MOLECULE INHIBITOR; TOPICAL TREATMENTS;

MEDICINE;

EID: 85042055496     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.1500973     Document Type: Article

References (68)

1. L. Xing, Z. Dai, A. Jabbari, J. E. Cerise, C. A. Higgins, W. Gong, A. de Jong, S. Harel, G. M. DeStefano, L. Rothman, P. Singh, L. Petukhova, J. Mackay-Wiggan, A. M. Christiano, R. Clynes, Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat. Med. 20, 1043-1049 (2014).
2. R. D. Paladini, J. Saleh, C. Qian, G.-X. Xu, L. L. Rubin, Modulation of hair growth with small molecule agonists of the hedgehog signaling pathway. J. Invest. Dermatol. 125, 638-646 (2005).
3. M. Cutolo, The kinase inhibitor tofacitinib in patients with rheumatoid arthritis: Latest findings and clinical potential. Ther. Adv. Musculoskelet. Dis. 5, 3-11 (2013).
4. T Zhou, S. Georgeon, R. Moser, D. J. Moore, A. Caflisch, O. Hantschel, Specificity andmechanismof-A ction of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348). Leukemia 28, 404-407 (2014).
5. R. A. Mesa, U. Yasothan, P. Kirkpatrick, Ruxolitinib. Nat. Rev. Drug Discov. 11, 103-104 (2012).
6. D. C. Borie, J. J. O'Shea, P. S. Changelian, JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants. Trends Mol. Med. 10, 532-541 (2004).
7. S. Verstovsek, R. A. Mesa, J. Gotlib, R. S. Levy, V. Gupta, J. F. DiPersio, J. V. Catalano, M. Deininger, C. Miller, R. T. Silver, M. Talpaz, E. F. Winton, J. H. Harvey Jr., M. O. Arcasoy, E. Hexner, R. M. Lyons, R. Paquette, A. Raza, K. Vaddi, S. Erickson-Viitanen, I. L. Koumenis, W. Sun, V. Sandor, H. M. Kantarjian, A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N. Engl. J. Med. 366, 799-807 (2012).
8. S. Müller-Röver, B. Handjiski, C. van der Veen, S. Eichmüller, K. Foitzik, I. A. McKay, K. S. Stenn, R. Paus, A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J. Invest. Dermatol. 117, 3-15 (2001).
9. M. V. Plikus, J. A. Mayer, D. de la Cruz, R. E. Baker, P. K. Maini, R. Maxson, C.-M. Chuong, Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration. Nature 451, 340-344 (2008).
10. M. V. Plikus, R. E. Baker, C.-C. Chen, C. Fare, D. de la Cruz, T. Andl, P. K. Maini, S. E. Millar, R. Widelitz, C.-M. Chuong, Self-organizing and stochastic behaviors during the regeneration of hair stem cells. Science 332, 586-589 (2011).
11. L. Alonso, E. Fuchs, The hair cycle. J. Cell Sci. 119, 391-393 (2006).
12. R. Schmidt-Ullrich, D. J. Tobin, D. Lenhard, P. Schneider, R. Paus, C. Scheidereit, NF-kB transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth. Development 133, 1045-1057 (2006).
13. I. Brownell, E. Guevara, C. B. Bai, C. A. Loomis, A. L. Joyner, Nerve-derived Sonic hedgehog defines a niche for hair follicle stem cells capable of becoming epidermal stem cells. Cell Stem Cell 8, 552-565 (2011).
14. W.-M. Woo, H. H. Zhen, A. E. Oro, Shh maintains dermal papilla identity and hair morphogenesis via a Noggin-Shh regulatory loop. Genes Dev. 26, 1235-1246 (2012).
15. Y. Ito, T. S. Hamazaki, K. Ohnuma, K. Tamaki, M. Asashima, H. Okochi, Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133. J. Invest. Dermatol. 127, 1052-1060 (2007).
16. Y.-C. Hsu, L. Li, E. Fuchs, Transit-amplifying cells orchestrate stem cell activity and tissue regeneration. Cell 157, 935-949 (2014).
17. P. Rabbani, M. Takeo, W. Chou, P. Myung, M. Bosenberg, L. Chin, M. M. Taketo, M. Ito, Coordinated activation of Wnt in epithelial and melanocyte stem cells initiates pigmented hair regeneration. Cell 145, 941-955 (2011).
18. R. M. Castilho, C. H. Squarize, L. A. Chodosh, B. O. Williams, J. S. Gutkind, mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging. Cell Stem Cell 5, 279-289 (2009).
19. A. J. Kellenberger, M. Tauchi, Mammalian target of rapamycin complex 1 (mTORC1) may modulate the timing of anagen entry in mouse hair follicles. Exp. Dermatol. 22, 77-80 (2013).
20. R. Schmidt-Ullrich, T. Aebischer, J. Hülsken, W. Birchmeier, U. Klemm, C. Scheidereit, Requirement of NF-kB/Rel for the development of hair follicles and other epidermal appendices. Development 128, 3843-3853 (2001).
21. S. Sano, S. Itami, K. Takeda, M. Tarutani, Y. Yamaguchi, H. Miura, K. Yoshikawa, S. Akira, J. Takeda, Keratinocytespecific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 18, 4657-4668 (1999).
22. S. Sano, M. Kira, S. Takagi, K. Yoshikawa, J. Takeda, S. Itami, Two distinct signaling pathways in hair cycle induction: Stat3-dependent and-independent pathways. Proc. Natl. Acad. Sci. U. S. A. 97, 13824-13829 (2000).
23. V. Greco, T. Chen, M. Rendl, M. Schober, H. A. Pasolli, N. Stokes, J. dela Cruz-Racelis, E. Fuchs, A two-step mechanism for stem cell activation during hair regeneration. Cell Stem Cell 4, 155-169 (2009).
24. A. Ferrajoli, S. Faderl, F. Ravandi, Z. Estrov, The JAK-STAT pathway: A therapeutic target in hematological malignancies. Curr. Cancer Drug Targets 6, 671-679 (2006).
25. D. Gay, O. Kwon, Z. Zhang, M. Spata, M. V. Plikus, P. D. Holler, M. Ito, Z. Yang, E. Treffeisen, C. D. Kim, A. Nace, X. Zhang, S. Baratono, F. Wang, D. M. Ornitz, S. E. Millar, G. Cotsarelis, Fgf9 fromdermal gd T cells induces hair follicle neogenesis after wounding. Nat. Med. 19, 916-923 (2013).
26. J. E. Kloepper, K. Kawai, M. Bertolini, T. Kanekura, R. Paus, Loss of gd T cells results in hair cycling defects. J. Invest. Dermatol. 133, 1666-1669 (2013).
27. D. Castellana, R. Paus, M. Perez-Moreno, Macrophages contribute to the cyclic activation of adult hair follicle stem cells. PLOS Biol. 12, e1002002 (2014).
28. A. Heine, S. A. E. Held, S. Nora Daecke, S. Wallner, S. Parampalli Yajnanarayana, C. Kurts, D. Wolf, P. Brossart, The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo. Blood 122, 1192-1202 (2013).
29. K. K. Lin, D. Chudova, G. W. Hatfield, P. Smyth, B. Andersen, Identification of hair cycleassociated genes from time-course gene expression profile data by using replicate variance. Proc. Natl. Acad. Sci. U. S. A. 101, 15955-15960 (2004).
30. K. S. Stenn, R. Paus, Control of hair follicle cycling. Physiol. Rev. 81, 449-494 (2001).
31. C. A. Higgins, J. C. Chen, J. E. Cerise, C. A. Jahoda, A. M. Christiano, Microenvironmental reprogramming by three-dimensional culture enables dermal papilla cells to induce de novo human hair-follicle growth. Proc. Natl. Acad. Sci. U. S. A. 110, 19679-19688 (2013).
32. Y. Zheng, X. Du, W. Wang, M. Boucher, S. Parimoo, K. Stenn, Organogenesis from dissociated cells: Generation of mature cycling hair follicles from skin-derived cells. J. Invest. Dermatol. 124, 867-876 (2005).
33. R. R. Driskell, A. Giangreco, K. B. Jensen, K. W. Mulder, F. M. Watt, Sox2-positive dermal papilla cells specify hair follicle type in mammalian epidermis. Development 136, 2815-2823 (2009).
34. M. Kawano, A. Komi-Kuramochi, M. Asada, M. Suzuki, J. Oki, J. Jiang, T. Imamura, Comprehensive analysis of FGF and FGFR expression in skin: FGF18 is highly expressed in hair follicles and capable of inducing anagen from telogen stage hair follicles. J. Invest. Dermatol. 124, 877-885 (2005).
35. H. Kamp, C. C. Geilen, C. Sommer, U. Blume-Peytavi, Regulation of PDGF and PDGF receptor in cultured dermal papilla cells and follicular keratinocytes of the human hair follicle. Exp. Dermatol. 12, 662-672 (2003).
36. M. Yu, S. Kissling, P. Freyschmidt-Paul, R. Hoffmann, J. Shapiro, Interleukin-6 cytokine family member oncostatin M is a hair-follicle-expressed factor with hair growth inhibitory properties. K. J. McElwee, Exp. Dermatol. 17, 12-19 (2008).
37. M. Rendl, L. Lewis, E. Fuchs, Molecular dissection of mesenchymal-epithelial interactions in the hair follicle. PLOS Biol. 3, e331 (2005).
38. M. Rendl, L. Polak, E. Fuchs, BMP signaling in dermal papilla cells is required for their hair follicle-inductive properties. Genes Dev. 22, 543-557 (2008).
39. R. Paus, K. Foitzik, P. Welker, S. Bulfone-Paus, S. Eichmüller, Transforming growth factor-b receptor type I and type II expression during murine hair follicle development and cycling. J. Invest. Dermatol. 109, 518-526 (1997).
40. K. Foitzik, R. Paus, T. Doetschman, G. P. Dotto, The TGF-b2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev. Biol. 212, 278-289 (1999).
41. N. Oshimori, E. Fuchs, Paracrine TGF-b signaling counterbalances BMP-mediated repression in hair follicle stem cell activation. Cell Stem Cell 10, 63-75 (2012).
42. P. Zhou, C. Byrne, J. Jacobs, E. Fuchs, Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate. Genes Dev. 9, 700-713 (1995).
43. K. Kratochwil, M. Dull, I. Farinas, J. Galceran, R. Grosschedl, Lef1 expression is activated by BMP-4 and regulates inductive tissue interactions in tooth and hair development. Genes Dev. 10, 1382-1394 (1996).
44. B. Hu, K. Lefort, W. Qui, B.-C. Nguyen, R. D. Rajaram, E. Castillo, F. He, Y. Chen, P. Angel, C. Brisken, G. P. Dotto, Control of hair follicle cell fate by underlying mesenchyme through a CSL-Wnt5a-FoxN1 regulatory axis. Genes Dev. 24, 1519-1532 (2010).
45. C. A. Ambler, F. M. Watt, Expression of Notch pathway genes in mammalian epidermis and modulation by b-catenin. Dev. Dyn. 236, 1595-1601 (2007).
46. A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, J. P. Mesirov, Gene set enrichment analysis: A knowledgebased approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102, 15545-15550 (2005).
47. Z. Wang, G. Li, W. Tse, K. D. Bunting, Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement. Blood 113, 4856-4865 (2009).
48. F. D. Price, J. von Maltzahn, C. F. Bentzinger, N. A. Dumont, H. Yin, N. C. Chang, D. H. Wilson, J. Frenette, M. A. Rudnicki, Inhibition of JAK-STAT signaling stimulates adult satellite cell function. Nat. Med. 20, 1174-1181 (2014).
49. M. T. Tierney, T. Aydogdu, D. Sala, B. Malecova, S. Gatto, P. L. Puri, L. Latella, A. Sacco, STAT3 signaling controls satellite cell expansion and skeletal muscle repair. Nat. Med. 20, 1182-1186 (2014).
50. J. Doles, M. Storer, L. Cozzuto, G. Roma, W. M. Keyes, Age-associated inflammation inhibits epidermal stem cell function. Genes Dev. 26, 2144-2153 (2012).
51. J. Goldstein, S. Fletcher, E. Roth, C. Wu, A. Chun, V. Horsley, Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation. Genes Dev. 28, 983-994 (2014).
52. S. J. Divito, T. S. Kupper, Inhibiting Janus kinases to treat alopecia areata. Nat. Med. 20, 989-990 (2014).
53. E. Festa, J. Fretz, R. Berry, B. Schmidt, M. Rodeheffer, M. Horowitz, V. Horsley, Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling. Cell 146, 761-771 2011).
54. C. A. B. Jahoda, A. M. Christiano, Niche crosstalk: Intercellular signals at the hair follicle. Cell 146, 678-681 (2011).
55. K. Turksen, T. Kupper, L. Degenstein, I. Williams, E. Fuchs, Interleukin 6: Insights to its function in skin by overexpression in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 89, 5068-5072 (1992).
56. M. H. Kwack, J. S. Ahn, M. K. Kim, J. C. Kim, Y. K. Sung, Dihydrotestosterone-inducible IL-6 inhibits elongation of human hair shafts by suppressing matrix cell proliferation and promotes regression of hair follicles in mice. J. Invest. Dermatol. 132, 43-49 (2012).
57. A. Quintás-Cardama, K. Vaddi, P. Liu, T. Manshouri, J. Li, P. A. Scherle, E. Caulder, X. Wen, Y. Li, P. Waeltz, M. Rupar, T. Burn, Y. Lo, J. Kelley, M. Covington, S. Shepard, J. D. Rodgers, P. Haley, H. Kantarjian, J. S. Fridman, S. Verstovsek, Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: Therapeutic implications for the treatment of myeloproliferative neoplasms. Blood 115, 3109-3117 (2010).
58. H. L. Geyer, R. A. Mesa, Therapy for myeloproliferative neoplasms: When, which agent, and how Blood 124, 3529-3537 (2014).
59. K. Ghoreschi, M. I. Jesson, X. LI, J. L. Lee, S. Ghosh, J. W. Alsup, J. D. Warner, M. Tanaka, S. M. Steward-Tharp, M. Gadina, C. J. Thomas, J. C. Minnerly, C. E. Storer, T. P. LaBranche, Z. A. Radi, M. E. Dowty, R. D. Head, D. M. Meyer, N. Kishore, J. J. O'Shea, Modulation of innate and adaptive immune responses by tofacitinib (CP-690, 550). J. Immunol. 186, 4234-4243 (2011).
60. H. Bachelez, P. C. van de Kerkhof, R. Strohal, A. Kubanov, F. Valenzuela, J. H. Lee, V. Yakusevich, S Chimenti, J. Papacharalambous, J. Proulx, P. Gupta, H. Tan, M. Tawadrous, H. Valdez, R. Wolk, Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: A phase 3 randomised non-inferiority trial. Lancet 386, 552-561 (2015).
61. N. Punwani, T. Burn, P. Scherle, R. Flores, J. Shi, P. Collier, D. Hertel, P. Haley, Y. Lo, P. Waeltz, J. Rodgers, S. Shepard, K. Vaddi, S. Yeleswaram, R. Levy, W. Williams, A. B. Gottlieb, Downregulation of key inflammatory cellmarkers with topical Janus kinase 1/2 inhibitor. Br. J. Dermatol., 10. 1111/bjd. 13994 (2015).
62. L. L. Levy, J. Urban, B. A. King, Treatment of reclacitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate. J. Am. Acad. Dermatol. 73, 395-399 (2015).
63. B. G. Craiglow, B. A. King, Tofacitinib citrate for the treatment of vitiligo: A pathogenesisdirected therapy. JAMA Dermatol. 10. 1001/jamadermatol. 2015. 1520 (2015).
64. B. G. Craiglow, B. A. King, Killing two birds with one stone: Oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis. J. Invest. Dermatol. 134, 2988-2990 (2014).
65. A. Jabbari, Z. Dai, L. Xing, J. E. Cerise, Y. Ramot, Y. Berkun, G. A. Sanchez, R. Goldbach-Mansky, A. M. Christiano, R. Clynes, A. Zlotogorski, Reversal of alopecia areata following treatment with the JAK1/2 inhibitor baricitinib. EBioMedicine 4, 351-355 (2015).
66. G. S. Eichler, S. Huang, D. E. Ingber, Gene Expression Dynamics Inspector (GEDI): For integrative analysis of expression profiles. Bioinformatics 19, 2321-2322 (2003).
67. D. J. Tobin, Ex Vivo Organ Culture of Human Hair Follicles: A Model Epithelial-Neuroectodermal-Mesenchymal Interaction System (Methods in Molecular Biology Series, Humana Press, New York, 2011), vol. 695, pp. 213-227.
68. U. Lichti, J. Anders, S. H. Yuspa, Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nat. Protoc. 3, 799-810 (2008).